Jeffrey Tornheim, MD, MPH

Titles:

Assistant Professor, Infectious Diseases, School of Medicine

SciVal:

SciVal Link

Jeff Tornheim, MD, MPH, is Assistant Professor in the Division of Infectious Diseases here at Johns Hopkins University School of Medicine. His research explores the application of new diagnostic technologies to improved health outcomes in the treatment of drug resistant tuberculosis among both adult and pediatric patients in India.

 

Dr. Tornheim completed a clinical fellowship in Infectious Diseases at Johns Hopkins after a combined residency in both internal medicine and pediatrics at Yale University School of Medicine. He received a BA in International Development and Economics from Brandeis University before moving to East Africa to work on strengthening health systems for returning refugees to South Sudan. In addition, he worked with the Centers for Disease Control and Prevention (CDC) International Emerging Infections Program on the epidemiology of pneumonia and diarrhea in Western Kenya. He received an MD/MPH from Mount Sinai School of Medicine, with thesis work evaluating the impact of water policy on rates of pediatric diarrhea in Bolivia. At the same time he worked at the Bureau of TB Control for the Department of Health and Mental Hygiene and was actively engaged in the operations of an East Harlem free clinic. Before finishing medicine, he spent 2 years in rural Bolivia to establish and manage operations for a Chagas Disease treatment program through the Fogarty International Clinical Scholars Program. His interest in clinical outcomes for underserved populations led him to practice in physician training environments in Bolivia, Peru, South Sudan, Kenya, Uganda, Rwanda, South Africa, and the United States.

 

He currently works with Drs. Amita Gupta, Kelly Dooley, Petros Karakousis, Vidya Mave, Bob Bollinger from Johns Hopkins, and with Drs. Zarir Udwadia, Camilla Rodrigues, and Tester Ashavaid from the P.D. Hinduja National Hospital and Medical Research Centre in Mumbai, India. His primary research activities include the epidemiology and microbiology of multidrug resistant tuberculosis (MDR-TB) in India, the use of whole genome sequencing as a tool to predict drug resistance and assess strain-relatedness for MDR-TB, and biomarkers of TB diagnosis and response to TB treatment.

Categories

Events

«

November 2019

»
S
M
T
W
T
F
S
·
·
·
·
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Projects

MDR TB treatment as prevention: modeling the...

We are using transmission modeling to evaluate the potential impact of expanding DST and access to MDR TB treatment in Vietnam,...

Read More

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More

TBM-KIDS (India)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More

TBM-KIDS (Malawi)

A phase 2 clinical trial of optimized treatment for pediatric tuberculous meningitis in India and Malawi

Read More